BILL · 2019–20 SESSION

SB 5251: Rx drug cost transparency

Concerning prescription drug cost transparency.

Summary

Requires issuers, pharmacy benefit managers (PBM), and pharmacy services administrative organizations (PSAO) to report certain prescription drug pricing data on a yearly basis to the Office of Financial Management (OFM).
Requires OFM to analyze the data from issuers, PBMs, and PSAOs and provide an annual report to the Legislature.
Requires drug manufacturers to report new drug applications to the Health Care Authority (HCA).
Requires HCA to compile an annual list of costly drugs and collect pricing data from manufacturers for those drugs.

From the Senate Bill Report (Orig.) (SB 5251), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to prescription drug cost transparency;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

SB 5251 (2025–26) Lodging tax revenues · Did not pass · died in committee
SB 5251 (2023–24) Commercial driver's licenses · Did not pass · stalled on the Senate floor
SB 5251 (2021–22) Tax and revenue laws · Enacted · Chapter 145, Laws of 2021
SB 5251 (2017–18) Tourism marketing · Enacted · Chapter 275, Laws of 2018
SB 5251 (2015–16) Public water syst assistance · Enacted · Chapter 111, Laws of 2016
SB 5251 (2013–14) B&O tax exemption for R&D · Did not pass · stalled on the Senate floor
SB 5251 (2011–12) Electric vehicle license fee · Did not pass · passed Senate, stalled in House
SB 5251 (2009–10) Pub records per page cost · Did not pass · died in committee